SI-BONE Q1 2024 GAAP EPS $(0.27) Beats $(0.32) Estimate, Sales $37.867M Beat $36.494M Estimate
Portfolio Pulse from Benzinga Newsdesk
SI-BONE (NASDAQ:SIBN) reported Q1 2024 earnings with a smaller loss per share of $(0.27) compared to the expected $(0.32), and sales of $37.867M, surpassing the $36.494M estimate. This represents a 15.62% improvement in EPS and a 15.77% increase in sales year-over-year.
May 06, 2024 | 8:48 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
SI-BONE reported a smaller than expected Q1 2024 loss and higher sales, indicating strong performance and potential growth.
Beating both EPS and sales estimates typically indicates a company's operational efficiency and market demand for its products or services. For SI-BONE, this could lead to increased investor confidence and a potential short-term uptick in its stock price, as the results surpassed analyst expectations and showed significant year-over-year growth.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100